XRCC1 gene polymorphisms and breast cancer risk in different populations: A meta-analysis

Breast

Volumn 18, Issue 3, 2009, Pages 183-191

  Li, Huihua ^a   Ha, Tam Cam ^a   Tai, Bee Choo ^b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Arg194Trp; Arg280His; Arg399Gln; Breast cancer; XRCC1 gene polymorphisms

Indexed keywords

ARGININE; GLUTAMINE; HISTIDINE; TRYPTOPHAN; XRCC1 PROTEIN;

ARTICLE; ASIAN; AUTOSOMAL INHERITANCE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; CLINICAL TRIAL; DNA POLYMORPHISM; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; META ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 67349253065     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.03.008     Document Type: Article

References (53)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 55 2 (2005) 74-108
2. McPherson K., Steel C.M., and Dixon J.M. ABC of breast diseases. Breast cancer - epidemiology, risk factors, and genetics. BMJ 321 7261 (2000) 624-628
3. Sim X., Ali R.A., Wedren S., Goh D.L.-M., Tan C.-S., Reilly M., et al. Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 6 (2006) 261
4. Ghafoor A., Jemal A., Ward E., Cokkinides V., Smith R., and Thun M. Trends in breast cancer by race and ethnicity. CA: A Cancer Journal for Clinicians 53 6 (2003) 342-355
5. Oldenburg R.A., Meijers-Heijboer H., Cornelisse C.J., and Devilee P. Genetic susceptibility for breast cancer: how many more genes to be found?. Critical Reviews in Oncology-Hematology 63 2 (2007) 125-149
6. Tudek B. Base excision repair modulation as a risk factor for human cancers. Molecular Aspects of Medicine 28 3-4 (2007) 258-275
7. Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis 19 8 (1998) 1329-1332
8. Moullan N., Cox D.G., Angele S., Romestaing P., Gerard J.-P., and Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiology, Biomarkers and Prevention 12 11 Pt 1 (2003) 1168-1174
9. Hamajima N., Takezaki T., and Tajima K. Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese. Asia Pacific Journal of Cancer Prevention 3 3 (2002) 197-206
10. Kiyohara C., Takayama K., and Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 54 3 (2006) 267-283
11. Hu Z., Ma H., Chen F., Wei Q., and Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiology, Biomarkers and Prevention 14 7 (2005) 1810-1818
12. Chacko P., Rajan B., Joseph T., Mathew B.S., and Pillai M.R. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Research and Treatment 89 1 (2005) 15-21
13. Brewster A.M., Jorgensen T.J., Ruczinski I., Huang H.Y., Hoffman S., Thuita L., et al. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Research and Treatment 95 1 (2005) 73-80
14. Smith T.R., Levine E.A., Perrier N.D., Miller M.S., Freimanis R.I., Lohman K., et al. DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 12 11 Pt 1 (2003) 1200-1204
15. Shen J., Gammon M.D., Terry M.B., Wang L., Wang Q., Zhang F., et al. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 14 2 (2005) 336-342
16. Han J., Hankinson S.E., De Vivo I., Spiegelman D., Tamimi R.M., Mohrenweiser H.W., et al. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk. Cancer Research 63 23 (2003) 8536-8541
17. Patel A.V., Calle E.E., Pavluck A.L., Feigelson H.S., Thun M.J., and Rodriguez C. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Research 7 6 (2005) R1168-R1173
18. Smith T.R., Miller M.S., Lohman K., Lange E.M., Case L.D., Mohrenweiser H.W., et al. Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Letters 190 2 (2003) 183-190
19. Zhang Y., Newcomb P.A., Egan K.M., Titus-Ernstoff L., Chanock S., Welch R., et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 15 2 (2006) 353-358
20. Pachkowski B.F., Winkel S., Kubota Y., Swenberg J.A., Millikan R.C., and Nakamura J. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Research 66 5 (2006) 2860-2868
21. Thyagarajan B., Anderson K.E., Folsom A.R., Jacobs Jr. D.R., Lynch C.F., Bargaje A., et al. No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study. Cancer Detection and Prevention 30 4 (2006) 313-321
22. Jin M., Chen K., Zhang S., Zhang Y., Ren Y., Xu H., et al. Association of single nucleotide polymorphisms and haplotypes in DNA repair gene XRCC1 with susceptibility of breast cancer. Journal of Zhejiang University Medical Sciences 35 4 (2006) 370-376
23. Deligezer U., and Dalay N. Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients. Experimental and Molecular Medicine 36 6 (2004) 572-575
24. Silva S.N., Moita R., Azevedo A.P., Gouveia R., Manita I., Pina J.E., et al. Menopausal age and XRCC1 gene polymorphisms: role in breast cancer risk. Cancer Detection and Prevention 31 4 (2007) 303-309
25. Mitra A.K., Singh N., Singh A., Garg V.K., Agarwal A., Sharma M., et al. Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women. Oncology Research 17 3 (2008) 127-135
26. Metsola K., Kataja V., Sillanpaa P., Siivola P., Heikinheimo L., Eskelinen M., et al. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Research 7 6 (2005) R987-R997
27. Costa S., Pinto D., Pereira D., Rodrigues H., Cameselle-Teijeiro J., Medeiros R., et al. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Research and Treatment 103 2 (2007) 209-217
28. Dufloth R.M., Costa S., Schmitt F., and Zeferino L.C. DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil. Genetics and Molecular Research 4 4 (2005) 771-782
29. Zhai X., Liu J., Hu Z., Wang S., Qing J., Wang X., et al. Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis. Oncology Reports 15 1 (2006) 247-252
30. Breast Cancer Association Consortium. Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. Journal of the National Cancer Institute 98 19 (2006) 1382-1396
31. Figueiredo J.C., Knight J.A., Briollais L., Andrulis I.L., and Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers and Prevention 13 4 (2004) 583-591
32. Saadat M., Kohan L., and Omidvari S. Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study. Breast Cancer Research and Treatment 111 3 (2008) 549-553
33. Saadat M., and Ansari-Lari M. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Research and Treatment 115 1 (2008) 137-144
34. Sangrajrang S., Schmezer P., Burkholder I., Waas P., Boffetta P., Brennan P., et al. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Research and Treatment 111 2 (2008) 279-288
35. Ali M.F., Meza J.L., Rogan E.G., and Chakravarti D. Prevalence of BER gene polymorphisms in sporadic breast cancer. Oncology Reports 19 4 (2008) 1033-1038
36. Romanowicz-Makowska H., Smolarz B., and Kulig A. Polymorphisms in XRCC1 and ERCC4/XPF DNA repair genes and associations with breast cancer risk in women. Pol Merkur Lekarski 22 129 (2007) 200-203
37. Bagos P.G., and Nikolopoulos G.K. A method for meta-analysis of case-control genetic association studies using logistic regression. Statistical Applications in Genetics and Molecular Biology 6 (2007) Article 17
38. Bagos P.G. A unification of multivariate methods for meta-analysis of genetic association studies. Statistical Applications in Genetics and Molecular Biology 7 (2008) Article 31
39. Minelli C., Thompson J.R., Abrams K.R., Thakkinstian A., and Attia J. The choice of a genetic model in the meta-analysis of molecular association studies. International Journal of Epidemiology 34 6 (2005) 1319-1328
40. Barrowman N.J., Fang M., Sampson M., and Moher D. Identifying null meta-analyses that are ripe for updating. BMC Medical Research Methodology 3 (2003) 13
41. Borm GF, Donders ART. Updating meta-analyses leads to larger type I errors than publication bias. Journal of Clinical Epidemiology, in press.
42. Kim S.-U., Park S.K., Yoo K.-Y., Yoon K.-S., Choi J.Y., Seo J.-S., et al. XRCC1 genetic polymorphism and breast cancer risk. Pharmacogenetics 12 4 (2002) 335-338
43. Sigurdson A.J., Hauptmann M., Chatterjee N., Alexander B.H., Doody M.M., Rutter J.L., et al. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer 4 (2004) 9
44. Duell E.J., Millikan R.C., Pittman G.S., Winkel S., Lunn R.M., Tse C.K., et al. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiology, Biomarkers and Prevention 10 3 (2001) 217-222
45. Loizidou M.A., Michael T., Neuhausen S.L., Newbold R.F., Marcou Y., Kakouri E., et al. Genetic polymorphisms in the DNA repair genes XRCC1, XRCC2 and XRCC3 and risk of breast cancer in Cyprus. Breast Cancer Research and Treatment 112 3 (2008) 575-579
46. Shu X.-O., Cai Q., Gao Y.-T., Wen W., Jin F., and Zheng W. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiology, Biomarkers and Prevention 12 12 (2003) 1462-1467
47. Försti A., Angelini S., Festa F., Sanyal S., Zhang Z., Grzybowska E., et al. Single nucleotide polymorphisms in breast cancer. Oncology Reports 11 4 (2004) 917-922
48. Bu D., Tomlinson G., Lewis C., Zhang C., Kildebeck E., and Euhus D. An intronic polymorphism associated with increased XRCC1 expression, reduced apoptosis and familial breast cancer. Breast Cancer Research and Treatment 99 3 (2006) 257-265
49. Kipikašová L., Wolaschka T., Bohuš P., Baumohlová H., Bober J., Blažejová J., et al. Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study. Pathology and Oncology Research (2008) 131-135
50. Tuimala J., Szekely G., Gundy S., Hirvonen A., and Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 23 6 (2002) 1003-1008
51. Wang Y., Spitz M.R., Zhu Y., Dong Q., Shete S., and Wu X. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair 2 8 (2003) 901-908
52. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., and Bell D.A. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Research 59 11 (1999) 2557-2561
53. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D., et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21 5 (2000) 965-971